4 line items for acyclovir tablets. Awarded for a base year of 3/11/2019-3/10/2020 with 4 one-year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79719D0011
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 36E79719R0002 Solicitation number
  • Acyclovir tablets Award Notice · Posted Nov 16, 2018
Last date to order 100% complete
IDV ceiling
$8,542,647.26
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Golden State Medical Supply, Inc. was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs National Acquisition Center to provide acyclovir tablets. With a potential value of $8.5 million, the contract has a base year of performance from March 11, 2019 through March 10, 2020 plus four one-year option periods extending through March 2024.

The contract facilitates delivery of standard pharmaceutical products to various government agencies on an as-needed basis. Golden State Medical Supply will supply acyclovir tablets to VA hospitals and other treatment facilities through March 2024, utilizing its distribution network under the terms of the IDV. As a large manufacturer and distributor of medications serving major customers like the VA and Defense Logistics Agency, Golden State Medical Supply is well positioned to reliably supply prescription acyclovir and other antiviral drugs to VA medical centers nationwide over the five-year ordering period established in the contract.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00008 · CRF and sales reporting update $0
Other Administrative Action P00007 · Unilateral modification is issued to incorporate updated dscsa language and requirements into VA national contract $0
Exercise an Option P00006 · Exercising option year 4 for acyclovir tablets without price changes to 36E79719D0011. Period of performance for the 3RD option year is 03/11/2023 - 03/10/2024. $0
Exercise an Option P00005 · Exercising option year 3 for acyclovir tablets without price changes to 36E79719D0011. Period of performance for the 3RD option year is 03/11/2022 - 03/10/2023. $0
Exercise an Option P00004 · Exercising option year 2 for acyclovir tablets without price changes to 36E79719D0011. Period of performance for the 2ND option year is 03/11/2021 - 03/10/2022. $0
Other Administrative Action P00003 · Change in point of contact for contract administration. $0
Other Administrative Action P00002 · Change of POC to 36E79719D0011. Remove kathleen mcdonough and add brian current. $0
Exercise an Option P00001 · 4 line items for acyclovir tablets. Exercising the 1ST option year from 3/11/2020-3/10/2021. Price increase on all 4 line items. $0
Original award $0

Quick answers

Who was awarded contract 36E79719D0011?

36E79719D0011 was awarded to Golden State Medical Supply, Inc. by National Acquisition Center (Headquarters) on March 11, 2019.

How much is contract 36E79719D0011 worth?

36E79719D0011's own ceiling is $8,542,647.

Who can order from contract 36E79719D0011?

36E79719D0011 is a single award indefinite delivery contract.

Was contract 36E79719D0011 competed?

The extent of competition for 36E79719D0011 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV